GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME

AGIO · Sep 30, 2024

AGIOS PHARMACEUTICALS, INC.. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.

STATE CAPABILITYLEVEL 3[email protected]

Inspectable configuration

State dimensions

Filing0001439222-24-000138General Corporate

Capex intensityRAWCurrent state valid · history insufficient

Evidence method

Level · gp.fundamentals.capex_revenue_ratio

4.67% · OPTIONAL · NOT_ENOUGH_HISTORY

Operating cash generationRAWCurrent state valid · history insufficient

Evidence method

Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue

-939.51% · OPTIONAL · NOT_ENOUGH_HISTORY

Inventory pressureRAWCurrent state valid · history insufficient

Evidence method

Level · gp.fundamentals.inventory_revenue_ratio

294.83% · OPTIONAL · NOT_ENOUGH_HISTORY

Gross marginRAWCurrent state valid · history insufficient

Evidence method

Level · gp.fundamentals.gross_margin

91.27% · CORE · NOT_ENOUGH_HISTORY

Operating marginRAWCurrent state valid · history insufficient

Evidence method

Level · gp.fundamentals.operating_margin

-1146.93% · CORE · NOT_ENOUGH_HISTORY

R&D intensityRAWCurrent state valid · history insufficient

Evidence method

Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue

808.29% · OPTIONAL · NOT_ENOUGH_HISTORY

SBC intensityRAWCurrent state valid · history insufficient

Evidence method

Level · gp.fundamentals.sbc_revenue_ratio

124.33% · OPTIONAL · NOT_ENOUGH_HISTORY

As-filed lineage

Fundamental state history

Each observation is tied to the filing and facts available at that report date. Amendments remain separate.

History9 statesHistory building

Jun 30, 20240/7 normalizedLevel 3 Sep 30, 20240/7 normalizedLevel 3 Dec 31, 20240/7 normalizedLevel 3 Mar 31, 20250/7 normalizedLevel 3 Jun 30, 20250/8 normalizedLevel 3 Sep 30, 20250/8 normalizedLevel 3 Dec 31, 20250/8 normalizedLevel 3 Mar 31, 20260/8 normalizedLevel 3 Jun 30, 20267/8 normalizedLevel 3

Period transition

What moved in the state?

Capex Intensity Increased

Previous: 1.83%
Current: 4.67%
Delta: 2.84%

Cash Generation Decreased

Previous: -842.59%
Current: -939.51%
Delta: -96.93%

Inventory Pressure Increased

Previous: 277.85%
Current: 294.83%
Delta: 16.98%

Margin Increased

Previous: 82.65%
Current: 91.27%
Delta: 8.62%

Profitability Increased

Previous: -1228.29%
Current: -1146.93%
Delta: 81.36%

R And D Intensity Decreased

Previous: 898.44%
Current: 808.29%
Delta: -90.16%

Sbc Intensity Decreased

Previous: 134.24%
Current: 124.33%
Delta: -9.91%

Self-history only

Previous similar states

Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.

Not enough compatible prior states for a transparent self-history match.

Research Graph

Related governed research

Transitioned To · AGIO Fundamental State →Transitioned To · AGIO Fundamental State →Transitioned To · AGIO CAPEX_INTENSITY_INCREASED →Transitioned To · AGIO CASH_GENERATION_DECREASED →Transitioned To · AGIO INVENTORY_PRESSURE_INCREASED →Transitioned To · AGIO MARGIN_INCREASED →Transitioned To · AGIO PROFITABILITY_INCREASED →Transitioned To · AGIO R_AND_D_INTENSITY_DECREASED →Transitioned To · AGIO SBC_INTENSITY_DECREASED →

Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.